| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 00:31:58 UTC |
|---|
| Update Date | 2021-09-26 22:57:16 UTC |
|---|
| HMDB ID | HMDB0247527 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol |
|---|
| Description | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol belongs to the class of organic compounds known as pyrrolo[2,1-f][1,2,4]triazines. These are aromatic heterocyclic compounds containing a pyrrolo[2,1-f][1,2,4]triazine ring system. Pyrrolo[2,1-f][1,2,4]triazine consists of a 1,2,4-triazine ring fused to and sharing the N2-atom with a pyrrole ring. Based on a literature review very few articles have been published on (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol. This compound has been identified in human blood as reported by (PMID: 31557052 ). (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N)C(O)C4)=C23)=C1 InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C19H24N6O2 |
|---|
| Average Molecular Weight | 368.441 |
|---|
| Monoisotopic Molecular Weight | 368.196074037 |
|---|
| IUPAC Name | 4-amino-1-({4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl}methyl)piperidin-3-ol |
|---|
| Traditional Name | 4-amino-1-({4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl}methyl)piperidin-3-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N)C(O)C4)=C23)=C1 |
|---|
| InChI Identifier | InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23) |
|---|
| InChI Key | CSGQVNMSRKWUSH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyrrolo[2,1-f][1,2,4]triazines. These are aromatic heterocyclic compounds containing a pyrrolo[2,1-f][1,2,4]triazine ring system. Pyrrolo[2,1-f][1,2,4]triazine consists of a 1,2,4-triazine ring fused to and sharing the N2-atom with a pyrrole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyrrolotriazines |
|---|
| Sub Class | Pyrrolo[2,1-f][1,2,4]triazines |
|---|
| Direct Parent | Pyrrolo[2,1-f][1,2,4]triazines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyrrolo[2,1-f][1,2,4]triazine
- Methoxyaniline
- Phenoxy compound
- Anisole
- Phenol ether
- Methoxybenzene
- Aniline or substituted anilines
- Alkyl aryl ether
- 4-aminopiperidine
- Aralkylamine
- Monocyclic benzene moiety
- Piperidine
- Substituted pyrrole
- Triazine
- Benzenoid
- Imidolactam
- 1,2,4-triazine
- Pyrrole
- Heteroaromatic compound
- Secondary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- 1,2-aminoalcohol
- Azacycle
- Ether
- Organic nitrogen compound
- Primary aliphatic amine
- Organonitrogen compound
- Organooxygen compound
- Alcohol
- Primary amine
- Amine
- Organic oxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 9.4426 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.84 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 397.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 210.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 114.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 175.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 61.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 285.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 876.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 597.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 47.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 512.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 177.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 228.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 611.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 546.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 255.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N)C(O)C4)=C23)=C1 | 4366.9 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N)C(O)C4)=C23)=C1 | 3384.5 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N)C(O)C4)=C23)=C1 | 3653.1 | Semi standard non polar | 33892256 |
Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #1 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)=C1 | 3515.7 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #1 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)=C1 | 3364.6 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #1 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)=C1 | 5049.8 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #2 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 3367.6 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #2 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 3224.6 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #2 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 5106.0 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O)C4)=C23)[Si](C)(C)C)=C1 | 3411.6 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O)C4)=C23)[Si](C)(C)C)=C1 | 3286.2 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O)C4)=C23)[Si](C)(C)C)=C1 | 4822.6 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #4 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O)C4)=C23)=C1 | 3626.2 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #4 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O)C4)=C23)=C1 | 3467.4 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TMS,isomer #4 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O)C4)=C23)=C1 | 5248.7 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 3389.8 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 3253.6 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 4403.5 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #2 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)=C1 | 3581.9 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #2 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)=C1 | 3418.1 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #2 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)=C1 | 4861.6 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O)C4)=C23)[Si](C)(C)C)=C1 | 3473.6 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O)C4)=C23)[Si](C)(C)C)=C1 | 3350.0 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O)C4)=C23)[Si](C)(C)C)=C1 | 4594.2 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,4TMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 3503.5 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,4TMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 3303.4 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,4TMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C4)=C23)[Si](C)(C)C)=C1 | 4240.3 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #1 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)=C1 | 3949.0 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #1 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)=C1 | 3786.8 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #1 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)=C1 | 5055.1 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #2 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3768.1 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #2 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3634.6 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #2 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 5040.1 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3839.4 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3692.9 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 4817.2 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #4 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C4)=C23)=C1 | 4097.2 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #4 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C4)=C23)=C1 | 3855.0 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,2TBDMS,isomer #4 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C4)=C23)=C1 | 5200.4 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3942.9 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3810.8 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 4494.5 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #2 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)=C1 | 4213.1 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #2 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)=C1 | 3984.1 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #2 | COC1=CC=CC(NC2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)=C1 | 4870.9 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 4121.1 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3882.0 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,3TBDMS,isomer #3 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 4610.8 | Standard polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,4TBDMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 4244.6 | Semi standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,4TBDMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 3948.7 | Standard non polar | 33892256 | | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol,4TBDMS,isomer #1 | COC1=CC=CC(N(C2=NC=NN3C=CC(CN4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C4)=C23)[Si](C)(C)C(C)(C)C)=C1 | 4361.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fb9-9428000000-beed3cfc164182f6a675 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol 10V, Positive-QTOF | splash10-014i-0009000000-263830b579c5c3e612d4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol 20V, Positive-QTOF | splash10-0uxr-0019000000-475d37a19107e2fecd7a | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol 40V, Positive-QTOF | splash10-0ue9-0596000000-cae7fe64a31bd6a62ce8 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol 10V, Negative-QTOF | splash10-014i-0009000000-4727d14bdffb5d1dae21 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol 20V, Negative-QTOF | splash10-014i-0039000000-f4fb227b9999cc186f2f | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol 40V, Negative-QTOF | splash10-0159-0795000000-93803ec57ef8a1433e82 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|